Research graph
References from Dissociation between humoral and multi-omic immune responses to inactivated COVID-19 vaccination in patients with pulmonary tuberculosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Vaccination of special populations: protecting the vulnerable
10.1016/j.vaccine.2016.11.015 · 2016 · External reference
Immune evasion and provocation by Mycobacterium tuberculosis
10.1038/s41579-022-00763-4 · 2022 · External reference
T-cell exhaustion in Mycobacterium tuberculosis and nontuberculous mycobacteria infection: pathophysiology and therapeutic perspectives
10.3390/microorganisms9122460 · 2021 · External reference
The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
10.1007/s10096-023-04566-0 · 2023 · External reference
T cell response in tuberculosis-infected patients vaccinated against COVID-19
10.3390/microorganisms11112810 · 2023 · External reference
Challenges to the effectiveness and immunogenicity of COVID-19 vaccines: a narrative review with a systematic approach
10.3390/vaccines13080789 · 2025 · External reference
Emerging technologies for systems vaccinology: multi-omics integration and single-cell (epi)genomic profiling
10.1016/j.coi.2020.05.001 · 2020 · External reference
The Immune Signatures data resource, a compendium of systems vaccinology datasets
10.1038/s41597-022-01714-7 · 2022 · External reference
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial
10.1080/14760584.2024.2425283 · 2024 · External reference
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
10.1038/s41591-021-01677-z · 2022 · External reference
Systems vaccinology
10.1016/j.immuni.2010.10.006 · 2010 · External reference
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
10.1038/s41541-023-00613-1 · 2023 · External reference
Emerging concepts in the science of vaccine adjuvants
10.1038/s41573-021-00163-y · 2021 · External reference
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
10.1038/s41586-021-03791-x · 2021 · External reference
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses
10.1038/s41590-022-01328-6 · 2022 · External reference
T cell receptor (TCR) signaling in health and disease
10.1038/s41392-021-00823-w · 2021 · External reference
CD4+ T-cell differentiation and function: unifying glycolysis, fatty acid oxidation, polyamines, NAD and mitochondria
10.1016/j.jaci.2021.03.033 · 2021 · External reference
Fighting persistence: how chronic infections with Mycobacterium tuberculosis evade T cell-mediated clearance and new strategies to defeat them
10.1128/iai.00916-19 · 2020 · External reference
Mycobacterium tuberculosis modulators of the macrophage's cellular events
10.1016/j.micinf.2012.07.001 · 2012 · External reference
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
10.1016/j.smim.2022.101672 · 2023 · External reference
The human plasma proteome: history, character, and diagnostic prospects
10.1074/mcp.r200007-mcp200 · 2002 · External reference
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
10.1038/nrg3185 · 2012 · External reference
T follicular helper cell biology: a decade of discovery and diseases
10.1016/j.immuni.2019.04.011 · 2019 · External reference
Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity
10.1002/eji.201040559 · 2010 · External reference
NF-kappaB signaling in inflammation
10.1038/sigtrans.2017.23 · 2017 · External reference
The special unfolded protein response in plasma cells
10.1111/imr.13012 · 2021 · External reference
The NFkappaB signaling system in the generation of B-cell subsets: from germinal center B cells to memory B cells and plasma cells
10.3389/fimmu.2023.1185597 · 2023 · External reference
Robust enumeration of cell subsets from tissue expression profiles
10.1038/nmeth.3337 · 2015 · External reference
Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China
10.7554/elife.84056 · 2023 · External reference
Comparative evaluation of Olink Explore 3072 and mass spectrometry with peptide fractionation for plasma proteomics
10.1038/s42004-025-01753-2 · 2025 · External reference
Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity
10.1002/eji.201040559 · ExternalCitation · doi-reference
The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
10.1007/s10096-023-04566-0 · ExternalCitation · doi-reference
Emerging technologies for systems vaccinology: multi-omics integration and single-cell (epi)genomic profiling
10.1016/j.coi.2020.05.001 · ExternalCitation · doi-reference
Systems vaccinology
10.1016/j.immuni.2010.10.006 · ExternalCitation · doi-reference
T follicular helper cell biology: a decade of discovery and diseases
10.1016/j.immuni.2019.04.011 · ExternalCitation · doi-reference
CD4+ T-cell differentiation and function: unifying glycolysis, fatty acid oxidation, polyamines, NAD and mitochondria
10.1016/j.jaci.2021.03.033 · ExternalCitation · doi-reference
Mycobacterium tuberculosis modulators of the macrophage's cellular events
10.1016/j.micinf.2012.07.001 · ExternalCitation · doi-reference
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
10.1016/j.smim.2022.101672 · ExternalCitation · doi-reference
Vaccination of special populations: protecting the vulnerable
10.1016/j.vaccine.2016.11.015 · ExternalCitation · doi-reference
Robust enumeration of cell subsets from tissue expression profiles
10.1038/nmeth.3337 · ExternalCitation · doi-reference
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
10.1038/nrg3185 · ExternalCitation · doi-reference
T cell receptor (TCR) signaling in health and disease
10.1038/s41392-021-00823-w · ExternalCitation · doi-reference
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
10.1038/s41541-023-00613-1 · ExternalCitation · doi-reference
Emerging concepts in the science of vaccine adjuvants
10.1038/s41573-021-00163-y · ExternalCitation · doi-reference
Immune evasion and provocation by Mycobacterium tuberculosis
10.1038/s41579-022-00763-4 · ExternalCitation · doi-reference
Systems vaccinology of the BNT162b2 mRNA vaccine in humans
10.1038/s41586-021-03791-x · ExternalCitation · doi-reference
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses
10.1038/s41590-022-01328-6 · ExternalCitation · doi-reference
Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
10.1038/s41591-021-01677-z · ExternalCitation · doi-reference
The Immune Signatures data resource, a compendium of systems vaccinology datasets
10.1038/s41597-022-01714-7 · ExternalCitation · doi-reference
Comparative evaluation of Olink Explore 3072 and mass spectrometry with peptide fractionation for plasma proteomics
10.1038/s42004-025-01753-2 · ExternalCitation · doi-reference
NF-kappaB signaling in inflammation
10.1038/sigtrans.2017.23 · ExternalCitation · doi-reference
The human plasma proteome: history, character, and diagnostic prospects
10.1074/mcp.r200007-mcp200 · ExternalCitation · doi-reference
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial
10.1080/14760584.2024.2425283 · ExternalCitation · doi-reference
The special unfolded protein response in plasma cells
10.1111/imr.13012 · ExternalCitation · doi-reference
Fighting persistence: how chronic infections with Mycobacterium tuberculosis evade T cell-mediated clearance and new strategies to defeat them
10.1128/iai.00916-19 · ExternalCitation · doi-reference
The NFkappaB signaling system in the generation of B-cell subsets: from germinal center B cells to memory B cells and plasma cells
10.3389/fimmu.2023.1185597 · ExternalCitation · doi-reference
T cell response in tuberculosis-infected patients vaccinated against COVID-19
10.3390/microorganisms11112810 · ExternalCitation · doi-reference
T-cell exhaustion in Mycobacterium tuberculosis and nontuberculous mycobacteria infection: pathophysiology and therapeutic perspectives
10.3390/microorganisms9122460 · ExternalCitation · doi-reference
Challenges to the effectiveness and immunogenicity of COVID-19 vaccines: a narrative review with a systematic approach
10.3390/vaccines13080789 · ExternalCitation · doi-reference
Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China
10.7554/elife.84056 · ExternalCitation · doi-reference
